+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 45Years +
All Genders
ID06869135

New Saliva Test Using Raman Spectroscopy for Early Detection and Monitoring of Neurodegenerative Diseases Including Alzheimers and Parkinsons

Led by Fondazione Don Carlo Gnocchi Onlus · Updated on 2025-08-07

242

Participants Needed

5

Research Sites

41 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying neurodegenerative diseases NDDs such as Parkinsons disease, atypical parkinsonisms, Alzheimers disease, prodromal Parkinsons disease, and mild cognitive impairment. The study focuses on early diagnosis and patient profiling using a novel, cost-effective biophotonic method involving Raman spectroscopy to analyze saliva and saliva-derived extracellular vesicles sEVs. This research aims to identify specific biochemical markers that can help in early detection, disease differentiation, and monitoring progression to improve personalized treatment strategies. Participants will provide saliva samples at enrollment and after 12 months to analyze biochemical changes using Raman spectroscopy. The study involves examining saliva and sEVs with advanced techniques to isolate and characterize extracellular vesicles. Data analysis will include molecular profiling and longitudinal evaluation to correlate biochemical fingerprints with disease stages and clinical assessments. The study includes groups representing different neurodegenerative conditions with a total minimum of 242 subjects. During the study, participants will undergo saliva collection using specialized swabs and provide demographic and clinical data, which will be pseudonymized and securely stored. Researchers will measure biochemical markers related to neurodegeneration and use Raman spectroscopy to create diagnostic profiles. Follow-up saliva samples and clinical evaluations after one year will help monitor disease progression. The primary outcome is the salivary Raman fingerprint distinguishing disease groups, with secondary outcomes including biomolecular evaluations and correlation with clinical data over 12 months.

CONDITIONS

Brief Title

Saliva and Extracellular Vesicles for Neurodegenerative Diseases

Research Team

P

Pietro Arcuri, MD

A

Alice Gualerzi, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here